溶栓治疗：一种仍在不断发展的方法。 - Suppr

Suppr

超能文献

Thrombolysis. An approach still on the move.

作者信息

Verstraete M

机构信息

Center for Thrombosis and Vascular Research, University of Leuven, Belgium.

出版信息

Drugs. 1989 Feb;37(2):116-22. doi: 10.2165/00003495-198937020-00002.

DOI:10.2165/00003495-198937020-00002

PMID:2495217

Abstract

摘要

相似文献

Thrombolysis. An approach still on the move.

Drugs. 1989 Feb;37(2):116-22. doi: 10.2165/00003495-198937020-00002.

Recombinant tissue plasminogen activator (rt-PA): is it the thrombolytic agent of choice for an evolving acute myocardial infarction?

Am J Cardiol. 1987 Apr 15;59(9):984-9. doi: 10.1016/0002-9149(87)91139-8.

Coronary thrombolysis.

Q J Med. 1988 Sep;68(257):657-63.

Clinical pharmacology of coronary thrombolysis.

Cardiol Clin. 1987 Feb;5(1):125-8.

Tissue-type plasminogen activator for acute coronary thrombosis.

Med Lett Drugs Ther. 1987 Dec 4;29(754):107-9.

Coronary thrombolysis.

Chest. 1989 Feb;95(2 Suppl):73S-87S. doi: 10.1378/chest.95.2_supplement.73s.

[New methods of thrombolysis].

Wien Med Wochenschr. 1987 Jun 15;137(10-11):221-4.

[Coronary thrombolysis by t-PA and pro-UK].

Nihon Rinsho. 1989 Apr;47(4):910-6.

Thrombolysis with recombinant human single-chain urokinase-type plasminogen activator (rscu-PA): dose-response in dogs with coronary artery thrombosis.

J Cardiovasc Pharmacol. 1987 Jan;9(1):91-3.

Pharmacologic thrombolysis: tissue-type plasminogen activator.

Circulation. 1987 Aug;76(2 Pt 2):II39-43.

引用本文的文献

Streptokinase. A review of its pharmacology and therapeutic efficacy in acute myocardial infarction in older patients.

Drugs Aging. 1994 Jan;4(1):63-86. doi: 10.2165/00002512-199404010-00007.

Intravenous streptokinase. A reappraisal of its therapeutic use in acute myocardial infarction.

Drugs. 1990 May;39(5):693-719. doi: 10.2165/00003495-199039050-00006.

本文引用的文献

Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction.

N Engl J Med. 1980 Oct 16;303(16):897-902. doi: 10.1056/NEJM198010163031601.

Fibrinolysis with acyl-enzymes: a new approach to thrombolytic therapy.

Nature. 1981 Apr 9;290(5806):505-8. doi: 10.1038/290505a0.

A murine monoclonal antibody that completely blocks the binding of fibrinogen to platelets produces a thrombasthenic-like state in normal platelets and binds to glycoproteins IIb and/or IIIa.

J Clin Invest. 1983 Jul;72(1):325-38. doi: 10.1172/jci110973.

Intracoronarily administered prostacyclin and streptokinase for treatment of myocardial infarction.

Adv Prostaglandin Thromboxane Leukot Res. 1983;11:385-90.

Recanalization of obstructed coronary artery by intracoronary administration of prostacyclin in patients with acute myocardial infarction.

Adv Prostaglandin Thromboxane Leukot Res. 1983;11:377-83.

Antibody-directed urokinase: a specific fibrinolytic agent.

Science. 1985 Aug 23;229(4715):765-7. doi: 10.1126/science.4023710.

Prevention of coronary thrombosis with subthrombolytic doses of tissue-type plasminogen activator.

Circulation. 1985 Dec;72(6):1346-54. doi: 10.1161/01.cir.72.6.1346.

Intravenous administration of a thrombolytic agent is the only realistic therapeutic approach in evolving myocardial infarction.

Eur Heart J. 1985 Jul;6(7):586-93. doi: 10.1093/oxfordjournals.eurheartj.a061906.

Intravenous and intracoronary fibrinolytic therapy in acute myocardial infarction: overview of results on mortality, reinfarction and side-effects from 33 randomized controlled trials.

Eur Heart J. 1985 Jul;6(7):556-85. doi: 10.1093/oxfordjournals.eurheartj.a061905.

Intracoronary prostaglandin E1 plus streptokinase in acute myocardial infarction.

Am J Cardiol. 1986 Dec 1;58(13):1161-6. doi: 10.1016/0002-9149(86)90375-9.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验